Circulating immune complexes in serum and in cerebrospinal fluid of patients with multiple sclerosis: Characterization and correlation with the clinical course

Acta Neurologica Scandinavica

Volumn 77, Issue 5, 1988, Pages 373-381

  Procaccia, S ^a   Lanzanova, D ^a   Caputo, D ^c   Ferrante, P ^b   Papini, E ^a   Gasparini, A ^a   Colucci, A ^a   Bianchi, M ^a   Villa, P ^a   Blasio, R ^a   Froldi, M ^a   Zanussi, C ^a  

^a Institute of Medicine and Immunopathology ^*  (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Hospital of Gallarate   (Italy)

Author keywords

characterization; clinical correlation; immune complexes; multiple sclerosis

Indexed keywords

ADOLESCENT; ADULT; ANTIGEN ANTIBODY COMPLEX; CEREBROSPINAL FLUID; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SERUM;

ADOLESCENT; ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGEN-ANTIBODY COMPLEX; BETA 2-MICROGLOBULIN; COMPLEMENT; HUMAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MIDDLE AGE; MOLECULAR WEIGHT; MULTIPLE SCLEROSIS;

EID: 0023891082     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1988.tb05922.x     Document Type: Article

References (43)

1. Immune complex assay: the first ten years
2. A WHO collaboratory study for the evaluation of eighteen methods for detecting immune complexes in serum
3. Lymphocyte function and the role of regulator cells in multiple sclerosis
4. T‐suppressor (Tg) lymphocytes fluctate in parallel with changes in the clinical course of patients with multiple sclerosis
5. Immunological changes in multiple sclerosis
6. Laboratory diagnosis of multiple sclerosis. Immunological and biochemical aspects
7. 1 and brain extracts in patients with multiple sclerosis and sub‐acute encephalitides
8. Multiple sclerosis: disturbed kappalambada light chains ratio of immuno‐globulins‐G in cerebrospinal fluid
9. The immunogenesis of the multiple sclerosis plaque
10. Immunofluorescence study of brain plaques from two patients with multiple sclerosis
11. Circulating immune complexes in multiple sclerosis and other neurological diseases
12. Circulating immune complexes in multiple sclerosis. Relation to clinical and biological parameters
13. Abnormal T cell subpopulations and circulating immune complexes in the Guillain‐Barrè syndrome and multiple sclerosis
14. Cerebrospinal fluid immune complexes in multiple sclerosis
15. Cerebrospinal‐fluid lymphocyte populations and immune complexes in active multiple sclerosis
16. Immune complexes in multiple sclerosis. Relation to clinical pattern
17. 125C1q binding, Raji cell binding, and lympho‐cytotoxic activity in multiple sclerosis
18. Soluble immune complexes in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases
19. Circulating immune complexes in neurological disease
20. Immune complexes in serum and cerebrospinal fluid of multiple sclerosis patients and patients with other neurological diseases
21. Diagnosis and classification of multiple sclerosis
22. Immunochemical quantitation of antigens by single radial immunodiffusion
23. The value of CSF immunoglobulin analysis in clinical neurology
24. IEF of proteins in thin layer of polyacrylamide gel
25. Complement and complement fixation
26. 125C1q binding test effect of heating on the binding of C1q by immune complexes and application of the test to systemic lupus erythematosus
27. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis: radioimmunoassay with monoclonal rheumatoid factor
28. An enzymatically active antigen‐antibody prove to measure circulating immune complexes by competition
29. Isolation of soluble immune complexes by affinity chromatography using staphylococcal protein A‐Sepharose as substrate
30. Detection of antibodies and soluble antigen‐antibody complexes by precipitation with polyethylene glycol
31. Protein measurement with the Folin phenol reagent
32. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
33. 2‐microglobulin in human biological fluids
34. Scléroses en plaques avec hipocomplémentémie et scléroses en plaques normocomplémentaires. Correlations cliniques et génétiques
35. Serum‐complement in multiple sclerosis
36. Circulating immune complexes and complement in the course of multiple sclerosis
37. Conglutinin microtiter plate ELISA system for detecting circulating immune complexes
38. Circulating immune complexes in patients with multiple sclerosis: a longitudinal study of serum and CSF by C1q and platelet binding tests
39. Immune complexes in cerebrospinal fluid and serum of neurological patients
40. Multiple sclerosis immune complexes: an analysis of component antigens and antibodies
41. 2‐microglobulin containing IgG complexes in sera and synovial fluids of rheumatoid arthritis and systemic lupus erythematosus patients
42. 2‐microglobulin in the intracellular processing of HLA antigens